IL79270A0 - Cloned antigen,its synthesis and vaccine containing it - Google Patents

Cloned antigen,its synthesis and vaccine containing it

Info

Publication number: IL79270A0
Authority: IL; Israel
Prior art keywords: synthesis; vaccine containing; cloned antigen; cloned; antigen
Prior art date: 1985-06-28

Application number

IL79270A

Other languages

English (en)

Original Assignee

Wellcome Found

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-06-28

Filing date

1986-06-27

Publication date

1986-09-30

1986-06-27 Application filed by Wellcome Found filed Critical Wellcome Found

1986-09-30 Publication of IL79270A0 publication Critical patent/IL79270A0/xx

Links

239000000427 antigen Substances 0.000 title 1
102000036639 antigens Human genes 0.000 title 1
108091007433 antigens Proteins 0.000 title 1
230000015572 biosynthetic process Effects 0.000 title 1
238000003786 synthesis reaction Methods 0.000 title 1
229960005486 vaccine Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Life Sciences & Earth Sciences (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

IL79270A 1985-06-28 1986-06-27 Cloned antigen,its synthesis and vaccine containing it IL79270A0 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB858516442A GB8516442D0 (en)	1985-06-28	1985-06-28	Cloned antigen

Publications (1)

Publication Number	Publication Date
IL79270A0 true IL79270A0 (en)	1986-09-30

Family

ID=10581498

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL79270A IL79270A0 (en)	1985-06-28	1986-06-27	Cloned antigen,its synthesis and vaccine containing it

Country Status (9)

Country	Link
EP (1)	EP0209281A1 (da)
JP (1)	JPS6251994A (da)
AU (1)	AU5941486A (da)
DK (1)	DK307986A (da)
ES (1)	ES2000255A6 (da)
FI (1)	FI862761L (da)
GB (1)	GB8516442D0 (da)
IL (1)	IL79270A0 (da)
ZA (1)	ZA864805B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8914122D0 (en) *	1989-06-20	1989-08-09	Wellcome Found	Polypeptide expression
US5601826A (en) *	1989-06-30	1997-02-11	The United States Of America As Represented By The Department Of Health And Human Services	Peptide which produces protective immunity against tetanus
GB9209118D0 (en) *	1992-04-28	1992-06-10	Sb 120 Amsterdam Bv	Vaccine compositions
AU4545393A (en) *	1992-06-30	1994-01-24	United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The	Peptide which produces protective immunity against tetanus
ATE174628T1 (de)	1992-07-31	1999-01-15	Medeva Holdings Bv	Expression rekombinanter fusionsproteine in attenuierten bakterien
GB9401787D0 (en) *	1994-01-31	1994-03-23	Medeva Holdings Bv	Vaccine compositions
WO1997035612A1 (fr)	1996-03-23	1997-10-02	The Research Foundation For Microbial Diseases Of Osaka University	Antigene a fragment fonctionnel de la toxine du tetanos, et vaccin contre le tetanos
US7923216B2 (en) *	1997-08-14	2011-04-12	Institut Pasteur	In vivo modulation of neuronal transport
GB9914861D0 (en) *	1999-06-25	1999-08-25	Imperial College	Tetanus toxin polypeptides
CZ20024224A3 (cs)	2000-06-29	2003-05-14	Glaxosmithkline Biologicals S. A.	Farmaceutický prostředek
GB0108364D0 (en)	2001-04-03	2001-05-23	Glaxosmithkline Biolog Sa	Vaccine composition
WO2006068794A2 (en)	2004-11-22	2006-06-29	New York University	Genetically engineered clostridial genes, proteins encoded by the engineered genes, and uses thereof
JP5814507B2 (ja)	2006-09-07	2015-11-17	グラクソスミスクラインバイオロジカルズソシエテアノニム	ワクチン
JP2010525035A (ja)	2007-05-02	2010-07-22	グラクソスミスクラインバイオロジカルズソシエテアノニム	ワクチン
EP2528941A4 (en)	2010-01-25	2013-05-29	Univ New York	FOR TRANSPORT STUDIES AND NEURONAL ADMINISTRATION, MANIPULATED RECOMBINANT DERIVATIVES FROM BOTULINUM NEUROTOXINES
GB201105981D0 (en)	2011-04-08	2011-05-18	Glaxosmithkline Biolog Sa	Novel process
US9315549B2 (en)	2013-01-28	2016-04-19	New York University	Treatment methods using atoxic neurotoxin derivatives
WO2014135651A1 (en)	2013-03-08	2014-09-12	Crucell Holland B.V.	Acellular pertussis vaccine
US11897921B2 (en)	2014-12-09	2024-02-13	New York University	Propeptide fusion comprising a mutated clostridium botulinum neurotoxin and a VHH domain
US11173199B2 (en) *	2019-11-13	2021-11-16	Alopexx Inc.	Low contaminant compositions
WO2022083585A1 (zh) *	2020-10-20	2022-04-28	上海瑞宙生物科技有限公司	一种蛋白多糖结合物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2634584C3 (de) *	1976-07-31	1979-11-08	Behringwerke Ag, 3550 Marburg	Atoxisches, immunogenes Produkt aus Tetanus-Toxin

1985
- 1985-06-28 GB GB858516442A patent/GB8516442D0/en active Pending
1986
- 1986-06-27 FI FI862761A patent/FI862761L/fi not_active IP Right Cessation
- 1986-06-27 EP EP86305029A patent/EP0209281A1/en not_active Withdrawn
- 1986-06-27 DK DK307986A patent/DK307986A/da not_active Application Discontinuation
- 1986-06-27 JP JP61149849A patent/JPS6251994A/ja active Pending
- 1986-06-27 IL IL79270A patent/IL79270A0/xx unknown
- 1986-06-27 AU AU59414/86A patent/AU5941486A/en not_active Abandoned
- 1986-06-27 ES ES8600021A patent/ES2000255A6/es not_active Expired
- 1986-06-27 ZA ZA864805A patent/ZA864805B/xx unknown

Also Published As

Publication number	Publication date
DK307986D0 (da)	1986-06-27
GB8516442D0 (en)	1985-07-31
ZA864805B (en)	1988-02-24
JPS6251994A (ja)	1987-03-06
AU5941486A (en)	1987-01-08
FI862761A7 (fi)	1986-12-29
EP0209281A1 (en)	1987-01-21
DK307986A (da)	1986-12-29
ES2000255A6 (es)	1988-02-01
FI862761L (fi)	1986-12-29
FI862761A0 (fi)	1986-06-27

Publication	Publication Date	Title
IL79270A0 (en)	1986-09-30	Cloned antigen,its synthesis and vaccine containing it
GB8622987D0 (en)	1986-10-29	Vaccines
EP0220693A3 (en)	1990-02-07	Acylamino silicon compounds, their use and preparation
IL78775A0 (en)	1986-08-31	Oral vaccines
IL68749A (en)	1988-07-31	Modified antigens,their preparation and vaccines containing them
EP0256878A3 (en)	1989-11-08	Vaccines
NZ215155A (en)	1989-01-06	Immunogens and compounds containing antigens and/or antigenic determinants
GB8702691D0 (en)	1987-03-11	Vaccines
EG17878A (en)	1991-06-30	Vaccine
OA08200A (en)	1987-10-30	Vaccine.
ZA862145B (en)	1986-11-26	Non-adjuvenated vaccine
EP0290565A4 (en)	1990-03-12	VACCINE CONTAINING TICK ANTIGENS.
ZA872532B (en)	1987-11-25	Combined vaccine
ZA874847B (en)	1988-01-13	Oncornavirus vaccines
PH25860A (en)	1991-12-02	Novel vaccines
PH22804A (en)	1988-12-12	Non-adjuvenated vaccine
GB8630851D0 (en)	1987-02-04	Babesia divergens antigen & vaccine
IL71798A0 (en)	1984-09-30	Babesiosis antigen,its preparation and vaccine containing it
ZA863612B (en)	1987-08-26	Oral vaccines
GB8605646D0 (en)	1986-04-16	Vaccines
ZA86374B (en)	1986-11-26	Vaccine
IE852561L (en)	1986-04-18	Vaccine
IE851380L (en)	1986-12-04	Vaccine
IE892714L (en)	1990-02-23	Cloned nophritis antigen
GB8621240D0 (en)	1986-10-08	Antigens